Correction to: No effects of COVID‑19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS‑CoV‑2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects

Acta Diabetol. 2023 Oct;60(10):1309. doi: 10.1007/s00592-023-02152-6.
No abstract available

Publication types

  • Published Erratum